Massive meningitis study aims to improve care in brazil

NCT ID NCT07027475

First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study is tracking how adults with meningitis are treated in about 30 hospitals across Brazil. Researchers will follow 624 patients during their hospital stay and after discharge to see what treatments work best and how patients recover. The goal is to gather real-world evidence to improve national care guidelines for meningitis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could provide real-world data to improve national guidelines for treating meningitis in adults.
What could go wrong
This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Results may not apply outside Brazil.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL MENINGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Municipal Dr Moysés Deutsch - M'Boi Mirim

    RECRUITING

    São Paulo, 04905020, Brazil

  • Hospital Santa Marcelina

    RECRUITING

    São Paulo, 08270-070, Brazil

  • Hospital São Vicente de Paulo

    RECRUITING

    Passo Fundo, Rio Grande do Sul, 99010-080, Brazil

  • Hospital Universitário Walter Cantídio

    ACTIVE_NOT_RECRUITING

    Fortaleza, Ceará, Brazil

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

    RECRUITING

    Ribeirão Preto, São Paulo, 14051-140, Brazil

  • Hospitalar Moinhos de Vento

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90560-032, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.